Renew Biopharma is a Delaware C Corporation based in San Diego, California, that was founded in 2017 by Michael Mendez. The company is focused on creating a pipeline of 100 percent pure, uncontaminated and non-psychoactive cannabinoids in quantities large enough to enable human therapeutic treatments. Renew uses molecular biology and pathway engineering instead of using agriculturally-grown Cannabis plants. Renew has a proprietary family of pharmacological chemical compounds - cannabinoids - specifically pure forms of CBG (cannabigerol) and CBD (cannabidiol). Renew's intellectual property includes both specific genes in the biosynthesis of cannabinoids and the ability to engineer a synthetic cannabinoid pathway into microorganisms, including microalgae.
Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington's Gill Center for Biomolecular Science Using Cannabinoids Grown in Microalgae
Documentaries, videos and podcasts
October 29, 2018